Halozyme to buy Elektrofi for $750 million to expand drug delivery lineup
01/10/2025 12:13
Oct 1 (Reuters) - Halozyme Therapeutics HALO.O said on Wednesday it will buy privately held Elektrofi for $750 million in cash, to expand its lineup with a technology that can deliver biologic medicines in small, concentrated doses. (Reporting by Padmanabhan Ananthan in Bengaluru) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Halozyme Therapeutics
See all newsUS RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Halozyme wins court order to block Merck's injected Keytruda in select European markets (updated)
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
Halozyme wins court order to block Merck's injected Keytruda in select European markets